Constellium SE
NYSEConstellium SE heads into its July 29 earnings report with the stock down 12% in a month, a fresh target cut from UBS landed just this week, and insiders who spent the spring selling into strength now watching shares trade below their exit prices. The analyst story frames the tension well. UBS trimmed its target to $35 from $38 on July 8 — the action is recent and worth noting…
CSTM cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for CSTM below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for CSTM are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 10 Jul 2026
Constellium SE heads into its July 29 earnings report with the stock down 12% in a month, a fresh target cut from UBS landed just this week, and insiders who spent the spring selling into strength now watching shares…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CSTM — free to start on ORTEX.
Sign up for free →Open CSTM on ORTEX